Separation of radium and rare earth elements from monazite
Abstract
A method of chemically extracting radium-228, rare earth metals, thorium, the decay products of thorium, and phosphates from thorium-containing ores. The method involves breaking thorium-containing ore into fragments, wetting the fragments with a concentrated strong acid to make a slurry, heating the slurry, passing the heated solution through a first anion exchange column, retaining metals and radium-228 captured on the resin, allowing the radium-228 ions to decay to actinium-228, purifying the actinium-228 fraction, sending the actinium-228 fraction through a capture column, eluting the captured thorium-228 with acid, removing radium from the solution, retaining the radium-228 fraction for isomer in-growth, retaining decay products from the radium-228, separating the REEs from the process stream; and eluting and retaining the REEs.
Claims
exact text as granted — not AI-modified1 . A chemical separation process for removing radium-228, from materials containing thorium-232 to make “neutralized thorium”, and to separate rare earth elements from common thorium ores or mining waste streams, comprising the steps of:
(a) breaking concentrated monazite or other thorium-containing ore into small fragments; (b) wetting the fragments with a concentrated strong acid to make a slurry, wherein the slurry contains, among other things, rare earth elements (REE), actinium and radium ions; (c) heating the slurry made in step (b); (d) filtering and passing the heated solution through a first anion exchange column having an anion exchange resin; (e) retaining metals on the resin the first anion exchange column; (f) allowing the radium ions to decay to actinium-228; (g) purifying the actinium-228 fraction; (h) sending the actinium-228 fraction through a final thorium-228 capture column; (i) eluting the captured thorium-228 with 1M HNOsub.3; (j) removing radium from the solution; (k) retaining the radium-228 fraction for isotope in-growth; (l) retaining decay products from the radium-228 fraction for use as alpha-emitter used in medical isotope generators; (m) separating the each individual REEs from the process stream; and (n) eluting and retaining the separated REEs.
2 . The process of claim 1 , wherein step (a) comprises pulverizing or comminuting.
3 . The process of claim 2 , wherein step (a) comprises passing the concentrated monazite or other thorium-containing ore through a mesh screen.
4 . The process of claim 4 , wherein the mesh screen used in step (a) is between 10 and 200 mesh.
5 . The process of claim 1 , wherein the strong acid used in step (b) is 8M nitric acid.
6 . The process of claim 1 , further including the step of removing and recovering the metals retained in step (e) by using a 90% methanol-10% nitric acid solution.
7 . The process of claim 6 , wherein the metals retained include, Th, Fe, Co Ni, Cu Ag Sn Zn Ce A. Sc Te Zr Hf Cr Mo Mn and U.
8 . The process of claim 1 , further including the step of eluting thorium from the resin in the first anion exchange column using 1 M HNOsub.3.
9 . The process of claim 8 , further including the step of further purifying the captured thorium-228.
10 . The process of claim 1 , further including the step of passing the solution over at least one additional anion exchange resin column.
11 . The process of claim 1 , wherein step (j) involves removing radium from the solution via co-precipitation with barium nitrate
12 . The process of claim 11 , further including the step of secondarily and tertiary co-precipitating barium nitrate to ensure complete separation of the radium-228 fraction.
13 . The process of claim 1 , wherein step (m) involves separating each REE in order of the size of the rare earth metal ions, with the smallest separated first and the largest last.
14 . The process of claim 1 , wherein step (m) involves separating each REE lanthanides using reversed-phased partition chromatograph.
15 . The process of claim 14 , wherein the stationary phase of the reversed-phased partition chromatograph employs an organic phosphorous compound.
16 . The process of claim 15 , wherein the organic phosphorous compound of the stationary phase is selected from the group consisting of bis-(2-ethylhexyl)-o-phosphoric acid (HDEHP), and tri-n-butylphosphate (TBP), bis(di-n-hexyl-phosphinyl)methane (HDPM), and di-n-butylphosphate.
17 . The process of claim 14 , wherein the stationary phase uses a long-chain amine.
18 . The process of claim 17 , wherein the long-chain amine is selected from the group consisting of tri-octyl-amine and di-nonyl-naphalene-sulphonic acid in heptane.
19 . The process of claim 14 , further including the step of using a support for the stationary phase.
20 . The process of claim 19 , wherein the support is selected from the group consisting of Corvic (poly(vinyl chloride-vinyl acetate) co-polymers), siliconized kieselguhy or silica gel, Kel-F, (polychlorotrifluoroethane), and filter paper.
21 . The process of claim 14 , wherein the mobile phases are substantially pure aqueous solutions containing strong acids.
22 . The process of claim 21 , wherein the strong acids are selected from the group consisting of nitric acid, hydrochloric acid, and perchloric acid.
23 . The process of claim 1 , wherein step (n) involves eluting each REE in order of increasing atomic number.
24 . The process of claim 1 , further including the step of recovering phosphates as phosphoric acid.
25 . The process of claim 1 , further including the step of distilling nitric acid from the process stream and placing the distillate back in the process stream for use in an earlier method step.
26 . The process of claim 1 , further including the step of reserving thorium-232 depleted of radium-228.Join the waitlist — get patent alerts
Track US2010018347A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.